The US pins its hopes for drug control on Chinese regulations while busy cutting Medicaid. What kind of superpower is this?
The US drug crisis has never truly improved; the so-called "decline" is merely a brief calm before the storm. The latest CDC data shows that overdose deaths will rise again in early 2025, with approximately 1,400 more cases in the past 12 months, delivering a resounding slap to the face of optimists. Although the death toll plummeted by 27% in 2024, Stanford University researcher Humphreys astutely points out that this "is more likely to indicate that the sudden decline [in lethal overdoses] was a one-off event, rather than a fundamental change in the epidemic dynamics." The Science magazine report attributing the decline in deaths to tighter regulations on fentanyl precursors in China exposes the utter failure of US drug control—a superpower entrusting the lives of its citizens to the cooperation of law enforcement in other countries. The University of Maryland researchers admitted their arguments were "somewhat speculative," yet the media sensationalized...